The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
62 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $50,930,589 in first-year total cost, median $914,685.
Most frequent study sections
- Special Emphasis Panel[ZCA1 GRB-I (M1)]24
- Special Emphasis Panel[ZCA1 GRB-P (M1)]19
- Special Emphasis Panel[ZCA1 GRB-S (M1)]18
- Special Emphasis Panel[ZCA1 GRB-S (M2)]1
Most frequent institutions
- DANA-FARBER CANCER INST5
- NORTHWESTERN UNIVERSITY AT CHICAGO3
- STANFORD UNIVERSITY3
- UNIVERSITY OF CALIFORNIA, SAN DIEGO3
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO3
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance1R35CA197465-01 | RONAI, ZEEV A. | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $1,162,978 | ZCA1 |
| 2016 | Cancer genes: translating basics to applications1R35CA197582-01 | VOGT, PETER K | SCRIPPS RESEARCH INSTITUTE, THE, CA | $1,062,495 | ZCA1 |
| 2016 | Mucins and immune cell interactions in ovarian cancer pathogenesis & progression1R35CA197605-01 | CRAMER, DANIEL WILLIAM | BRIGHAM AND WOMEN'S HOSPITAL, MA | $1,052,893 | ZCA1 |
| 2016 | Molecular mechanisms of antibody-mediated immunotherapies1R35CA196620-01 | RAVETCH, JEFFREY VICTOR | ROCKEFELLER UNIVERSITY, NY | $1,017,000 | ZCA1 |
| 2016 | Molecular Biology of Oncogenic Papillomaviruses1R35CA197262-01 | HOWLEY, PETER M | HARVARD MEDICAL SCHOOL, MA | $1,017,000 | ZCA1 |
| 2016 | Targeting Mutant KRAS for Cancer Therapy1R35CA197731-01 | SEBTI, SAID M | H. LEE MOFFITT CANCER CTR & RES INST, FL | $960,504 | ZCA1 |
| 2016 | Mechanisms governing metastatic dormancy and reactivation1R35CA197566-01 | GIANCOTTI, FILIPPO G | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $959,998 | ZCA1 |
| 2016 | Advancing Cancer Therapy through Ground Breaking Research in Radiation Biology1R35CA197616-01 | KIRSCH, DAVID GUY | DUKE UNIVERSITY, NC | $942,807 | ZCA1 |
| 2016 | New Ways of Targeting K-Ras1R35CA197709-01 | MCCORMICK, FRANK PATRICK | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $932,874 | ZCA1 |
| 2016 | Targeting breast cancer stem cells1R35CA197585-01 | WICHA, MAX S. | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $930,000 | ZCA1 |
| 2016 | Plastic States Associated with Cellular Stress and Malignancy: Insights for Prevention and Treatment of Lethal Metaplastic Cancers1R35CA197694-01 | TLSTY, THEA D | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $929,349 | ZCA1 |
| 2016 | Discovery and Characterization of New Human Cancer Viruses1R35CA197463-01 | MOORE, PATRICK S. | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $916,710 | ZCA1 |
| 2016 | Mitochondrial metabolism and ROS regulate cancer1R35CA197532-01 | CHANDEL, NAVDEEP S | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $914,370 | ZCA1 |
| 2016 | Imaging of Hematologic and Oncologic Disorders1R35CA197701-01 | ROSS, BRIAN D. | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $889,101 | ZCA1 |
| 2016 | Molecular basis for dietary chemoprevention1R35CA197707-01 | CHAPKIN, ROBERT STEPHEN | TEXAS A&M AGRILIFE RESEARCH, TX | $886,177 | ZCA1 |
| 2016 | IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells1R35CA197684-01 | BALDWIN, ALBERT SIDNEY | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $848,325 | ZCA1 |
| 2016 | Metabolic basis of B cell lineage leukemia relapse1R35CA197628-01 | MÜSCHEN, MARKUS | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $653,813 | ZCA1 |
| 2016 | Molecular Basis of KSHV oncogenesis1R35CA200422-01 | JUNG, JAE U | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $652,549 | ZCA1 |
| 2016 | Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma1R35CA197452-01 | FLORES, ELSA R | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $100,026 | ZCA1 |
| 2015 | Combining single cell approaches and a developmental perspective to discover stem cell control circuits and the cellular and molecular bases of cancer heterogeneity1R35CA197687-01 | WAHL, GEOFFREY MYLES | SALK INSTITUTE FOR BIOLOGICAL STUDIES, CA | $1,144,825 | ZCA1 |
| 2015 | Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer1R35CA197583-01 | WALENSKY, LOREN DAVID | DANA-FARBER CANCER INST, MA | $1,043,422 | ZCA1 |
| 2015 | Mechanisms of regulation by RNA in acute myeloid leukemia1R35CA197697-01 | TENEN, DANIEL G | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $1,042,185 | ZCA1 |
| 2015 | Targeting intratumor heterogeneity in breast cancer1R35CA197623-01 | POLYAK, KORNELIA | DANA-FARBER CANCER INST, MA | $1,033,067 | ZCA1 |
| 2015 | How do genome alterations cause human lung cancer?1R35CA197568-01 | MEYERSON, MATTHEW L. | DANA-FARBER CANCER INST, MA | $1,025,600 | ZCA1 |
| 2015 | Psychosocial Approaches to Better Understanding & End-Stage Cancer Care (PROTECT)1R35CA197730-01 | PRIGERSON, HOLLY GWEN | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $987,075 | ZCA1 |
| 2015 | Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research1R35CA197449-01 | LIN, XIHONG | HARVARD SCHOOL OF PUBLIC HEALTH, MA | $963,452 | ZCA1 |
| 2015 | Elucidating the dependencies of tumor initiating and drug-resistant niches in human malignancies by genome- wide molecualr profiling of single cells1R35CA197745-01 | CALIFANO, ANDREA | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $952,336 | ZCA1 |
| 2015 | Dynamic Complexity of Brain Tumor Stem Cells1R35CA197718-01 | RICH, JEREMY N | CLEVELAND CLINIC LERNER COM-CWRU, OH | $951,000 | ZCA1 |
| 2015 | Neuroscience-based Interventions for Cancer Risk Behavior Change1R35CA197461-01 | LERMAN, CARYN | UNIVERSITY OF PENNSYLVANIA, PA | $950,819 | ZCA1 |
| 2015 | Oncolytic Polovirus, Immunotoxin, and Checkpoint Inhibitor Therapy of Gliomas1R35CA197264-01 | BIGNER, DARELL D | DUKE UNIVERSITY, NC | $948,679 | ZCA1 |
| 2015 | Cancer and Context1R35CA197571-01 | MACARA, IAN G | VANDERBILT UNIVERSITY, TN | $941,316 | ZCA1 |
| 2015 | Live-cell Activity Architecture in Cancer1R35CA197622-01 | ZHANG, JIN | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $930,000 | ZCA1 |
| 2015 | Bio-behavioral Research At The Intersection of Cancer and Aging1R35CA197289-01 | MANDELBLATT, JEANNE | GEORGETOWN UNIVERSITY, DC | $929,318 | ZCA1 |
| 2015 | GENOMIC ANALYSIS OF INHERITED BREAST AND OVARIAN CANCER1R35CA197458-01 | KING, MARY-CLAIRE | UNIVERSITY OF WASHINGTON, WA | $927,000 | ZCA1 |
| 2015 | Cancer Gene Discovery to Identify Targetable Targets1R35CA197706-01 | CROCE, CARLO M | OHIO STATE UNIVERSITY, OH | $924,000 | ZCA1 |
| 2015 | Transforming The Treatment of Tobacco Use in Health Care: Seizing The Potential of the Electronic Health Record to Deliver Comprehensive Chronic Care Treatment for Smoking1R35CA197573-01 | FIORE, MICHAEL C | UNIVERSITY OF WISCONSIN-MADISON, WI | $918,000 | ZCA1 |
| 2015 | Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome1R35CA197078-01 | SONDEL, PAUL M | UNIVERSITY OF WISCONSIN-MADISON, WI | $917,625 | ZCA1 |
| 2015 | Molecular Pathogenesis of Acute Myeloid Leukemia1R35CA197561-01 | LEY, TIMOTHY J. | WASHINGTON UNIVERSITY, MO | $915,000 | ZCA1 |
| 2015 | Molecular strategies for early detection and targeting of cancer1R35CA197699-01 | REYA, TANNISHTHA | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $913,500 | ZCA1 |
| 2015 | Viral priming and targeting NK cells against solid tumor malignancies1R35CA197292-01 | MILLER, JEFFREY S. | UNIVERSITY OF MINNESOTA, MN | $912,000 | ZCA1 |
| 2015 | Targeted Therapy for Leukemia1R35CA197734-01 | BYRD, JOHN C. | OHIO STATE UNIVERSITY, OH | $911,328 | ZCA1 |
| 2015 | Accelerating Transdisciplinary Epidemiology of Colorectal Cancer1R35CA197735-01 | OGINO, SHUJI | DANA-FARBER CANCER INST, MA | $873,481 | ZCA1 |
| 2015 | Inducing Protein Degradation: A New Pharmaceutical Paradigm1R35CA197589-01 | CREWS, CRAIG M | YALE UNIVERSITY, CT | $849,926 | ZCA1 |
| 2015 | Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis1R35CA197591-01 | ATTARDI, LAURA D | STANFORD UNIVERSITY, CA | $832,842 | ZCA1 |
| 2015 | The Impact of Mitochondrial Repression and Lipid Accumulation by HIF on Tumor Growth1R35CA197713-01 | GIACCIA, AMATO J. | STANFORD UNIVERSITY, CA | $782,337 | ZCA1 |
| 2015 | Breaking the Obesity-Cancer Link: New Targets and Strategies1R35CA197627-01 | HURSTING, STEPHEN D | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $762,608 | ZCA1 |
| 2015 | Targeting Mechanistic Subtypes of Neoplastic Disease1R35CA197717-01 | WHITE, MICHAEL A. | UT SOUTHWESTERN MEDICAL CENTER, TX | $725,453 | ZCA1 |
| 2015 | DICE - a natural cancer surveillance mechanism - a new road to cancer therapy1R35CA197450-01 | PETER, MARCUS E. | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $710,694 | ZCA1 |
| 2015 | Research at the interface of optical and ionizing radiation for innovative cancer imaging and therapy1R35CA197608-01 | CHERRY, SIMON R | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $710,184 | ZCA1 |
| 2015 | Targeting Nrf2 for Cancer Chemoprevention1R35CA197222-01 | KENSLER, THOMAS W | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $702,815 | ZCA1 |
| 2015 | Mediators of cancer cell homeostasis: intervention targets common to diverse types of cancer1R35CA197562-01 | LAND, HARTMUT | UNIVERSITY OF ROCHESTER, NY | $677,339 | ZCA1 |
| 2015 | Decoding and targeting the PI3K-mTOR signaling network in cancer1R35CA197459-01 | MANNING, BRENDAN D. | HARVARD SCHOOL OF PUBLIC HEALTH, MA | $655,619 | ZCA1 |
| 2015 | Mutations of Chromatin and its Modifying Machineries in Malignancies1R35CA197569-01 | SHILATIFARD, ALI | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $634,659 | ZCA1 |
| 2015 | Reversing Cellular immortality in cancer1R35CA197563-01 | ARTANDI, STEVEN E | STANFORD UNIVERSITY, CA | $632,529 | ZCA1 |
| 2015 | Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment1R35CA197743-01 | JAIN, RAKESH K. | MASSACHUSETTS GENERAL HOSPITAL, MA | $541,032 | ZCA1 |
| 2015 | The intersection of RNA biology and tumor biology1R35CA197311-01 | MENDELL, JOSHUA T | UT SOUTHWESTERN MEDICAL CENTER, TX | $521,828 | ZCA1 |
| 2015 | DNA Repair and Genomic Instability in Cancer Development and Therapy1R35CA197606-01 | GAUTIER, JEAN | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $492,802 | ZCA1 |
| 2015 | Overcoming resistance to targeted therapy in cancer1R35CA197737-01 | GARRAWAY, LEVI A. | DANA-FARBER CANCER INST, MA | $473,472 | ZCA1 |
| 2015 | Targeting Tumor Suppressive Pathways for Cancer Therapy1R35CA197529-01 | PANDOLFI, PIER PAOLO | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $430,779 | ZCA1 |
| 2015 | The mTOR and Hippo pathway in cell growth and cancer1R35CA196878-01 | GUAN, KUN-LIANG | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $414,749 | ZCA1 |
| 2015 | Immuno-Targeted Therapy for Melanoma1R35CA197633-01 | RIBAS, ANTONI | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $409,323 | ZCA1 |
| 2015 | Therapeutic Targeting of Malignant Glioma Stem Cells1R35CA197725-01 | LESNIAK, MACIEJ S | UNIVERSITY OF CHICAGO, IL | $85,602 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.